Vai al contenuto
MediHelp
MediHelp Riferimento sui farmaci

Interazioni tra farmaci

Deutetrabenazine + Tranylcypromine

Gravità: Controindicata

Deutetrabenazine and Tranylcypromine: contraindicated interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Deutetrabenazine depletes monoamines by inhibiting VMAT2, and combining it with an MAOI is contraindicated per labeling. The pairing may cause unpredictable blood pressure and heart rate changes and can destabilize mood or autonomic control.

Cosa significa questa interazione in parole semplici

Deutetrabenazine and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Deutetrabenazine belongs to Central Nervous System; Tranylcypromine belongs to Central Nervous System.

Livello di evidenza: Moderate

Perché avviene

VMAT2 inhibition alters monoamine storage while MAO inhibition prevents breakdown, producing unpredictable adrenergic effects.

Cosa fare

Do not coadminister, and wait at least 14 days after stopping an MAOI before starting deutetrabenazine. Use another treatment for chorea or tardive dyskinesia if an MAOI is required.

Cosa chiedere al farmacista

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Deutetrabenazine e Tranylcypromine, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription
Crea un account gratuito Accedi

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Deutetrabenazine with Tranylcypromine?

MediHelp rates the interaction as contraindicated. Deutetrabenazine and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Deutetrabenazine depletes monoamines by inhibiting VMAT2, and combining it with an MAOI is contraindicated per labeling. The pairing may cause unpredictable blood pressure and heart rate changes and can destabilize mood or autonomic control.

How serious is the interaction between Deutetrabenazine and Tranylcypromine?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not coadminister, and wait at least 14 days after stopping an MAOI before starting deutetrabenazine. Use another treatment for chorea or tardive dyskinesia if an MAOI is required.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Scarica suApp Store Disponibile suGoogle Play

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi